As my fellow panellist said, it's an organically evolving system. I've been writing on it since it started in 2011, and at least every two years we publish an article on it. It's getting better year over year.
Is it a good system? Yes. Could it be a lot better? Oh yes.
It's definitely not perfect, as I think I've laid out, and it's not the full nationalized pharmacare program, but it certainly is stepped to national collaboration and general frameworks for it that everyone can draw on and access prices that they otherwise couldn't.
For Atlantic Canada, where I understand you're from, Mr. Chair, I think it's been an amazing success. The listing rates in Atlantic Canada have gone up significantly because they can get access to better prices, which they just couldn't get under the previous system.